---
figid: PMC5834602__41598_2018_22233_Fig6_HTML
figlink: /pmc/articles/PMC5834602/figure/Fig6/
number: F6
caption: Summary. When insulin sensitivity is improved at the level of the IR in podocytes,
  either through IR over-expression or PTP1B knockdown, podocytes are protected from
  the development of ER stress. However, knockdown of PTEN, which improves insulin
  sensitivity through the PI3K-Akt pathway downstream of insulin, potentiates ER stress.
  Inhibition of mitogen-activated protein kinase kinase (MEK) or extracellular signal-regulated
  kinase (ERK) protects podocytes from ER stress. (IRS, insulin receptor substrate).
pmcid: PMC5834602
papertitle: Enhanced insulin receptor, but not PI3K, signalling protects podocytes
  from ER stress.
reftext: Kathryn L. Garner, et al. Sci Rep. 2018;8:3902.
pmc_ranked_result_index: '100129'
pathway_score: 0.9241093
filename: 41598_2018_22233_Fig6_HTML.jpg
figtitle: Enhanced insulin receptor, but not PI3K, signalling protects podocytes from
  ER stress
year: '2018'
organisms: Homo sapiens
ndex: c14eb973-deaa-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5834602__41598_2018_22233_Fig6_HTML.html
  '@type': Dataset
  description: Summary. When insulin sensitivity is improved at the level of the IR
    in podocytes, either through IR over-expression or PTP1B knockdown, podocytes
    are protected from the development of ER stress. However, knockdown of PTEN, which
    improves insulin sensitivity through the PI3K-Akt pathway downstream of insulin,
    potentiates ER stress. Inhibition of mitogen-activated protein kinase kinase (MEK)
    or extracellular signal-regulated kinase (ERK) protects podocytes from ER stress.
    (IRS, insulin receptor substrate).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT3
  - PTPN1
  - MAP2K2
  - PTEN
  - MAPK1
  - MAP2K1
  - AKT2
  - IRS2
  - IRS4
  - IRS1
  - MAPK3
  - fatty acids
  - Diabetic
genes:
- word: '`Akt'
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: '`Akt'
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PTP1B
  symbol: PTP1B
  source: hgnc_prev_symbol
  hgnc_symbol: PTPN1
  entrez: '5770'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: '`Akt'
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
chemicals:
- word: fatty acids
  source: MESH
  identifier: D005227
diseases:
- word: Diabetic
  source: MESH
  identifier: D003920
figid_alias: PMC5834602__F6
redirect_from: /figures/PMC5834602__F6
figtype: Figure
---
